When did Eupraxia (EPRX) last report earnings?

Eupraxia last reported on Nov 4, 2025, covering fiscal Q3 2025.

Did EPRX beat earnings estimates?

No. Eupraxia reported EPS of −$0.19 for Q3 2025 against a −$0.18 estimate — a 7.96% miss.

Eupraxia (EPRX) earnings history

Most recent quarter

Fiscal period: Q3 2025
Period end: Sep 30, 2025
EPS actual: −$0.19
EPS estimate: −$0.18
EPS surprise: −7.96%
Revenue surprise: +0.00%
Revenue: $0.00
Revenue estimate: $0.00
Reported: Nov 4, 2025
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q3 2025	Nov 4, 2025	−$0.18	−$0.19	−7.96%	$0.00	SEC
Q2 2025	Aug 13, 2025	−$0.19	−$0.24	−29.91%	$0.00	SEC
Q1 2025	May 6, 2025	−$0.17	−$0.18	−8.16%	$0.00	SEC
Q3 2024	Nov 7, 2024	−$0.13	−$0.12	+4.74%	$0.00	SEC
Q2 2024	Aug 7, 2024	−$0.17	−$0.12	+26.68%	$0.00	SEC

Quarterly revenue

Q2 2024

$0.00

Q3 2024

$0.00

Q1 2025

$0.00

Q2 2025

$0.00

Q3 2025

$0.00

Frequently asked questions

When did Eupraxia (EPRX) last report earnings?
Eupraxia last reported on Nov 4, 2025, covering fiscal Q3 2025.
Did EPRX beat earnings estimates?
No. Eupraxia reported EPS of −$0.19 for Q3 2025 against a −$0.18 estimate — a 7.96% miss.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by